The online Comment window has expired

Agenda Item

21-396 Discussion and Action on the Janssen Settlement Agreement, waiving future claims against Janssen Pharmaceuticals (Johnson & Johnson) related to the national opioid epidemic, in order to participate in a national settlement; and Discussion and Action on the Distributors Settlement Agreement, waiving future claims against certain opioid distributors (Mckesson Corporation, Cardinal Health, Inc., and AmerisourceBergen Corporation) related to the national opioid epidemic, in order to participate in a national settlement.